Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed…
E-posters highlighting preclinical data demonstrate the potential of Nirogy’s small molecule therapies to enable significant activation of anti-tumor immunity and…
The Company expects to completely self-fund all operations going forwardLOS ANGELES, March 16, 2021 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have paid off all outstanding toxic convertible debt and…
Intertrade Shipping AS har mandag 15. mars kjøpt 1.500.000 aksjer i Vistin Pharma ASA forNOK 23,60 pr. aksje. Intertrade Shipping AS eier etter kjøpet 12.575.000 aksjeri Vistin Pharma AS, tilsvarende 28,4 % av utestående aksjer i selskapet.Intertrade S…
Press Release 16 March 2021 Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination Immunicum AB (publ; IMMU.ST) announced today the establishment of an updated executive management team following the initial int…
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmissionAccurate detection and differentiation of SARS-CoV-2 mutations can help assess the spread of circul…
SUNFISH Part 2 study population includes broad range of ages and disease severities, representing a real-world spectrum of people living with Type 2 or 3 SMAEvrysdi is the first and only at home SMA treatment approved by the FDA, and has proven efficac…
MARSEILLE, France, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2…
Marseille, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2 p.m. CE…
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) — We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor Summit” issued March 11, 2021, over GlobeNewswire.